In this study, our data showed that DKK1 levels in serum and tissues are significantly higher in human and mouse HCC, which is consistent with the results of previous studies, which is the rationale for our study to investigate the effects of DKK1 inhibitor in HCC. The gene discussed is DKK1; the disease is hepatocellular carcinoma.